Skip to content Skip to footer


The fundamental B2B building blocks that companies need to succeed in the cannabis industry.


Our influential series of B2B conferences and expos bridge the gap between cannabis and the mainstream. They provide the platform for cannabis businesses, brands, investors and policymakers to connect, get deals done and build ongoing commercial relationships. These pivotal events are attended by thousands of delegates from over 50 countries annually.


Our reliable and credible data on commercial opportunities, market size and the regulatory environment in key cannabis markets globally provides our 300,000 monthly readers with actionable business insights. This global community also trusts our respected range of digital media titles to keep them informed on the latest industry developments through a variety of multimedia content.


Through technology, we’re removing many of the barriers preventing exponential growth for Europe’s cannabis industry and the businesses that operate within it. We’re powering cannabis commerce by providing a trusted space where buyers can make safe and informed purchases, and sellers can distinguish and grow their business. A space where product quality is obvious and payments are painless.

Data &

B2B Cannabis Technology

Media &

Events &

About Us

Prohibition Partners is the discovery platform for B2B cannabis with fully integrated solutions across conferences, content and commerce. The company was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world.

Our Brands

Our portfolio includes some of the most widely used and respected brands in the global cannabis industry.

2023 Reports & Market Sizing Bundle
A bundle of four industry-leading reports and market sizing data worth £6190. Together, these reports and datasets provide unprecedented insight into various markets and aspects of the global cannabis industry. All of the reports and market sizing forecasts were publ...
PRE-ORDER | The Global Cannabis Report: 4th Edition
The Global Cannabis Report: 4th Edition provides the most comprehensive overview of, and analysis into, all major cannabis markets globally - broken down by region. It provides an overview of the development of cannabis markets at an international level and considers...
The Cannabis Testing Report
The Cannabis Testing Report offers comprehensive and invaluable insights into the critical aspect of cannabis testing. Packed with meticulously researched data, industry analysis, and expert commentary, this report is a must-have resource for stakeholders seeking to ...
Website Product Images_Cover_new
The Pharmaceutical Cannabis Report: 3rd Edition
Use code BF42 for 42% Black Friday discount until 5th December. Co-authored in collaboration with Cannabiscientia, this report gives a clear and detailed account of all activity involving cannabis and cannabinoids in the landscape of pharmaceutical medicine, at a ...
photo_2023-04-11 11.14.39
The European Adult-Use Cannabis Report
Use code BF42 for 42% Black Friday discount until 5th December. A 70+ page report on adult-use markets in Europe is available to purchase, focusing on developments in Germany, Czech Republic, Switzerland and the Netherlands. This package also includes adult-use ma...
The European Cannabis Report: 8th Edition
Use code BF42 for 42% Black Friday discount until 5th December. The European Cannabis Report: 8th Edition, 2023 provides the latest information and analysis on the development of the cannabis markets across Europe. Included in the report are deep dives into all ke...

Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe

Co-authored by Prohibition Partners and Cannabiscientia SA,  this publication is intended to be of support to European healthcare professionals, and all those interested in understanding the medical use of cannabis in Europe. In a single eBook, it provides a comprehensive overview of the science, regulations, medicine and products on the market.

Topics covered include the physiology of the endocannabinoid system, the pharmacology of cannabis and its clinical relevance for a number of pathologies. The Handbook also includes case studies and practical evidence of experienced prescribers around the globe that can serve as a guiding support in the obstacles of translating theory to practical applications.

Latest Insights

November 9, 2023
AVAILABLE NOW | The Cannabis Testing Report
Published today, The Cannabis Testing Report offers comprehensive and invaluable insights into the critical aspect of cannabis testing. Packed with...
Pharma Report PP Hero
August 30, 2023
AVAILABLE NOW | The Pharmaceutical Cannabis Report: 3rd Edition
Prohibition Partners are pleased to announce the publication of The Pharmaceutical Cannabis Report: 3rd Edition, which is now available to...
Pharma Report PP Hero
July 12, 2023
The Pharmaceutical Cannabis Report: 3rd Edition Now Available to Pre-Order
Prohibition Partners are pleased to announce that The Pharmaceutical Cannabis Report: 3rd Edition is now available to pre-order, prior to...
May 23, 2023
European Medical Cannabis: At a Glance
The European medical cannabis industry has seen steady growth over the past year and it is projected to reach over...

Events & Conferences

Cannabis Europa London

Location: London, UK

Date: 25-26 June, 2024

Join 1,500+ influential leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians — the crucial combination needed to drive the European cannabis industry and your business forward.

Business of Cannabis: New York

Location: New York, US

Date: TBC, 2024

Business of Cannabis: New York will once again bring together the most influential leaders in policy, business, law and finance together to focus on the new capital of cannabis: New York. Join us for the next instalment of BofCNY.

As Trusted By



on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.